Font Size: a A A
Keyword [Structure-based]
Result: 81 - 100 | Page: 5 of 7
81. Structure-based design and synthesis of small-molecules directed towards novel antimicrobial drug discovery
82. Structure-based drug design: What to do when you don't have a structure
83. Discovery of novel small molecule enzyme inhibitors and receptor modulators through structure-based computational design
84. Design of Novel Inhibitors for Infectious Diseases using Structure-based Drug Design: Virtual Screening, Homology Modeling and Molecular Dynamics
85. Structure based design of peptidomimetic inhibitors of the MLL1-WDR5 interaction
86. Structure-based design of sickling inhibitors
87. Use of modern structure-based drug design techniques in the discovery and development of novel antimicrobial candidates
88. Structure-based design of novel inhibitors of plasmepsins: A family of anti-malarial targets
89. Structure-based drug-design software tool
90. Protein Flexibility In Structure-Based Drug Design
91. Development of computational tools for structure-based drug design
92. Informatics in drug discovery: Identifying transcription factor targets and structure-based drug screening
93. Crystallographic, molecular dynamics, and enzymatic studies of multi-drug resistant HIV-1 protease and implications for structure based drug design (project 1); crystallographic studies of human myelin protein zero (project 2)
94. Homology modeling of the smooth and skeletal myosin light chain kinase: Implications for structure based drug design and ligand specificity
95. Integrating structure-based drug design and multivalency for creating effective antagonists of cholera toxin and Escherichia coli heat-labile enterotoxin
96. Structure-based design and characterization of ricin and Shiga toxin inhibitors
97. Computational methods for structure-based drug design and macromolecular crystallization
98. Computational methods for structure-based and combinatorial drug design
99. Cholera toxin and heat-labile enterotoxin: Structural studies of assembly and design of active A-subunit constructs
100. Crystallographic studies of sialidase and structure-based design of inhibitors
  <<First  <Prev  Next>  Last>>  Jump to